Kirill I. Kirgizov

Suggest Changes
Learn More
Autologous hematopoietic stem cell transplantation (aHSCT) is a promising therapy for multiple sclerosis (MS), which has mainly been used in adults. The purpose of this study was to investigate(More)
  • 1